Financial results: Bioxyne/BLS; Emyria; Ecofibre; Zelira Therapeutics by Martin Lane October 3, 2023April 30, 2024 ASX-listed Bioxyne has released its first annual report since it acquired Breathe Life Sciences (BLS) in […]
Ecofibre shares soar 50% after firm strikes deal with Under Armour by Steve Jones July 31, 2023April 30, 2024
Ecofibre facing financial hit after hemp seed is damaged in transit by Steve Jones July 19, 2023April 30, 2024
Company news: Asterion; Ecofibre; Avecho; Epsilon Healthcare; Creso Pharma; Cann Global by Martin Lane and Steve Jones May 18, 2023April 30, 2024
Ecofibre writes down A$12m as subdued CBD market continues to impact sales by Steve Jones February 20, 2023April 30, 2024
Second trial flagged by Ecofibre in bid to get S3 product over the line by Steve Jones February 1, 2023February 1, 2023
Ecofibre becomes second company to confirm disappointing sleep trial results by Steve Jones January 30, 2023March 13, 2023
Company news: Emyria; Ecofibre; Avecho; Medlab; MGC Pharma; AusCann; Botanix; Incannex; GFI by Martin Lane and Steve Jones November 1, 2022April 29, 2024